
PainReform Ltd. PRFX
€ 2.30
1.12%
Geschäftsbericht 2025
hinzugefügt 11.04.2026
PainReform Ltd. ROE 2011-2026 | PRFX
ROE Jährlich PainReform Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -58.78 | -799.78 | -129.08 | -79.77 | -40.07 | -24.39 | 10.45 | 7.47 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.45 | -799.78 | -139.24 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.88 | 3.89 % | $ 9.34 B | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 323.46 | -2.98 % | $ 42.4 B | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Burford Capital Limited
BUR
|
10.1 | $ 4.7 | -0.63 % | $ 766 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Cabaletta Bio
CABA
|
-149.8 | $ 3.55 | 4.26 % | $ 357 M | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-45.18 | $ 8.1 | 9.16 % | $ 80.1 M | ||
|
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
103.22 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.44 | $ 21.91 | 1.04 % | $ 1.02 B | ||
|
CymaBay Therapeutics
CBAY
|
-36.05 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
1.11 | $ 101.31 | 1.85 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.07 | -3.15 % | $ 5.05 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
Galectin Therapeutics
GALT
|
24.11 | $ 2.3 | -10.35 % | $ 147 M | ||
|
ContraFect Corporation
CFRX
|
549.72 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-16.39 | $ 1.39 | -10.32 % | $ 357 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Grifols, S.A.
GRFS
|
9.2 | $ 8.57 | -1.44 % | $ 6.83 B | ||
|
Aquestive Therapeutics
AQST
|
248.9 | $ 4.21 | -0.71 % | $ 450 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 23.86 | -2.93 % | $ 3.04 B | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
45.18 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.54 | 3.02 % | $ 410 M | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
6.58 | - | 0.49 % | $ 251 B | ||
|
Immatics N.V.
IMTX
|
1.79 | $ 10.75 | -2.27 % | $ 676 M | ||
|
Checkpoint Therapeutics
CKPT
|
445.47 | - | - | $ 169 M | ||
|
Incyte Corporation
INCY
|
24.9 | $ 95.06 | -2.11 % | $ 18.6 B | ||
|
Caladrius Biosciences
CLBS
|
-67.58 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
204.15 | - | - | $ 25.3 M |